Synthesis, Crystal Structure, and Biological Activity of Ethyl 4-Methyl-2,2-dioxo-1H-2 lambda(6),1-benzothiazine-3-carboxylate Polymorphic Forms

被引:8
|
作者
Ukrainets, Igor V. [1 ]
Burian, Anna A. [1 ]
Baumer, Vyacheslav N. [2 ]
Shishkina, Svitlana V. [2 ,3 ]
Sidorenko, Lyudmila V. [1 ]
Tugaibei, Igor A. [4 ]
Voloshchuk, Natali I. [5 ]
Bondarenko, Pavlo S. [5 ]
机构
[1] Natl Univ Pharm, Dept Pharmaceut Chem, 53 Pushkinska St, UA-61002 Kharkov, Ukraine
[2] Natl Acad Sci Ukraine, SSI Inst Single Crystals, 60 Nauki Ave, UA-61001 Kharkov, Ukraine
[3] Kharkov Natl Univ, Dept Inorgan Chem, 4 Svobody Sq, UA-61077 Kharkov, Ukraine
[4] Kharkiv Med Acad Postgrad Educ, Dept Clin Biochem Forens Toxicol & Pharm, 58 Amosov St, UA-61176 Kharkov, Ukraine
[5] NI Pirogov Vinnitsa Natl Med Univ, Dept Pharmacol, 56 Pirogov St, UA-21018 Vinnitsa, Ukraine
关键词
alkylation esters; 4-methyl-2,2-dioxo-1H-2 lambda(6); 1-benzothiazine-3-carboxylic acid; 2,1-benzothiazine; crystal structure; polymorphism; anti-inflammatory action; analgesic activity;
D O I
10.3390/scipharm86020021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Continuing the search for new potential analgesics among the derivatives of 4-methyl-2,2-dioxo-1H-2 lambda(6),1-benzothiazine-3-carboxylic acid, the possibility of obtaining its esters by the alkylation of the corresponding sodium salt with iodoethane in dimethyl sulfoxide (DMSO) at room temperature was studied. It was found that under such conditions, together with the oxygen atom of the carboxyl group, a heteroatom of nitrogen is also alkylated. Therefore, the product of the reaction studied is a mixture of ethyl 4-methyl-2,2-dioxo-1H-2 lambda(6),1-benzothiazine-3-carboxylate (major) and its 1-ethyl-substituted analog (minor). A simple but very effective method of preparative separation of these compounds was proposed. Moreover, the heterogeneous crystallization from ethanol was revealed to result in a monoclinic polymorphic form of ethyl 4-methyl-2,2-dioxo-1H-2 lambda(6),1-benzothiazine-3-carboxylate, while the homogeneous crystallization results in its orthorhombic form. The molecular and crystal structures of both forms were confirmed by X-ray diffraction analysis, and the phase purity by powder diffraction study. The pharmacological tests carried out on the model of a carrageenan edema showed that the screening dose of 20 mg/kg of 1-ethyl-substituted ester and the orthorhombic form of its analog unsubstituted in position 1 exhibited weak anti-inflammatory and moderate analgesic effects. At the same time, the monoclinic form of ethyl 4-methyl-2,2-dioxo-1H-2 lambda(6),1-benzothiazine-3-carboxylate appeared to be both a powerful analgesic and an anti-inflammatory agent that exceeded Piroxicam and Meloxicam in the same doses by these indicators. A detailed comparative analysis of the molecular and crystal structures of two polymorphic forms of ethyl 4-methyl-2,2-dioxo-1H-2 lambda(6),1-benzothiazine-3-carboxylate was carried out using quantum chemical calculations of the energies of pairwise interactions between molecules. An explanation of the essential differences of their biological properties based on this was offered.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Molecular and crystal structure of methyl 4-methyl-2,2-dioxo-1H-2 lambda(6),1-benzothiazine-3-carboxylate
    Shishkina, Svitlana
    Ukrainets, Igor
    Hamza, Ganna
    Grinevich, Lina
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2018, 74 : 1299 - +
  • [2] Methyl 1-allyl-4-hydroxy-2,2-dioxo-1H-2 lambda(6),1-benzothiazine-3-carboxylate
    Shishkina, Svitlana V.
    Ukrainets, Igor V.
    Petrushova, Lidiya A.
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1698 - +
  • [3] Synthesis and Molecular Structure of Ethyl-4-Hydroxy-1-Phenyl-2,2-Dioxo-1H-2λ6,1-Benzothiazine-3-Carboxylate
    Ukrainets, I. V.
    Petrushova, L. A.
    Sim, G.
    Grinevich, L. A.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2017, 51 (06) : 482 - 485
  • [4] Synthesis and Molecular Structure of Ethyl-4-Hydroxy-1-Phenyl-2,2-Dioxo-1H-2λ6,1-Benzothiazine-3-Carboxylate
    I. V. Ukrainets
    L. A. Petrushova
    G. Sim
    L. A. Grinevich
    Pharmaceutical Chemistry Journal, 2017, 51 : 482 - 485
  • [5] 4-Methyl-2,2-dioxo-1H-2 lambda(6),1-benzothiazine-3-carboxylic Acid. Peculiarities of Preparation, Structure, and Biological Properties
    Ukrainets, Igor V.
    Hamza, Ganna M.
    Burian, Anna A.
    Shishkina, Svitlana V.
    Voloshchuk, Natali I.
    Malchenko, Oxana V.
    SCIENTIA PHARMACEUTICA, 2018, 86 (01)
  • [6] Methyl 5-chloro-4-hydroxy-2,2-dioxo-1H-2λ6,1-benzothiazine-3-carboxylate: structure and Hirshfeld surface analysis
    Shishkina, Svitlana, V
    Petrushova, Lidiya A.
    Burian, Kateryna O.
    Fedosov, Andrii, I
    Ukrainets, Igor, V
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2020, 76 : 1657 - +
  • [7] Effect of Bromination on the Pharmacological Properties of Methyl 1-Allyl-4-Hydroxy-2,2-Dioxo-1H-2λ6,1-Benzothiazine-3-Carboxylate
    Ukrainets, I. V.
    Petrushova, L. A.
    Bereznyakova, N. L.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2015, 49 (08) : 519 - 522
  • [8] Methyl 4-Hydroxy-2,2-Dioxo-1H-2λ6,1-Benzothiazine-3-Carboxylate and Its Analogs Modified in the Benzene Moiety of the Molecule as New Analgesics
    Ukrainets, Igor, V
    Petrushova, Lidiya A.
    Shishkina, Svitlana, V
    Sidorenko, Lyudmila, V
    Alekseeva, Tatiana, V
    Torianyk, Inna I.
    Davidenko, Alexandra A.
    SCIENTIA PHARMACEUTICA, 2020, 88 (01)
  • [9] 2,1-Benzothiazine 2,2-Dioxides. 9*. Alkylation of Methyl 4-Hydroxy-1-Methyl-2,2-Dioxo-1Н-2λ6,1-Benzothiazine-3-Carboxylate with Ethyl Iodide
    I. V. Ukrainets
    L. A. Petrushova
    S. V. Shishkina
    G. Sim
    Chemistry of Heterocyclic Compounds, 2015, 50 : 1741 - 1747
  • [10] Molecular Conformations and Biological Activity of N-Hetaryl(aryl)alkyl-4-methyl-2,2-dioxo-1H-2 lambda(6),1-benzothiazine-3-carboxamides
    Ukrainets, Igor V.
    Hamza, Ganna M.
    Burian, Anna A.
    Voloshchuk, Natali I.
    Malchenko, Oxana V.
    Shishkina, Svitlana V.
    Grinevich, Lina A.
    Grynenko, Vasyl V.
    Sim, Galina
    SCIENTIA PHARMACEUTICA, 2018, 86 (04)